Small Molecule Antagonists of the CXCR2 and CXCR1 Chemokine Receptors as Therapeutic Agents for the Treatment of Inflammatory Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|6|13|1345-1352

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.6, Iss.13, 2006-01, pp. : 1345-1352

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting of Th1-Associated Chemokine Receptors CXCR3 and CCR5 as Therapeutic Strategy for Inflammatory Diseases

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-11 ,pp. : 1089-1096

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecule CXCR4 Chemokine Receptor Antagonists: Developing Drug Candidates

By  

Current Medicinal Chemistry, Vol. 14, Iss. 21, 2007-09 ,pp. : 2257-2277

Bentham Science Publishers

Access to resources Recommend Favorite

Small molecule antagonists of chemokine receptors as emerging anti-HIV agents

By Mastrolorenzo Antonio   Scozzafava Andrea   Supuran Claudiu T  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 8, 2001-08 ,pp. : 1245-1252

Informa Healthcare

Access to resources Recommend Favorite

The therapeutic potential of CXCR4 antagonists in the treatment of HIV

By Fujii Nobutaka   Nakashima Hideki   Tamamura Hirokazu  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 185-195

Informa Healthcare

Access to resources Recommend Favorite

The Chemokine Receptor CXCR4 as a Therapeutic Target for Several Diseases

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 9, 2006-09 ,pp. : 989-995

Bentham Science Publishers

Access to resources Recommend Favorite